Therapeutic Efficacy Study of AL and DP in Western Kenya

NCT05060198 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

DRUG: Artemether-lumefantrine (AL)
DRUG: Dihydroartemisinin-piperaquine (DP)

Sponsor

Kenya Medical Research Institute

Collaborators

[object Object]